Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MULTIPLE SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05269628
What this trial is testing

Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype

Who this might be right for
Multiple SclerosisSleepPain
Tiffany J. Braley, MD, MS 166
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Not applicableUnknownNCT06256471
What this trial is testing

The Impact of Parasitic Infection on Multiple Sclerosis and Nephrotic Syndrome

Who this might be right for
Parasitic Disease
Assiut University 200
Large-scale testing (Phase 3)Study completedNCT04353492
What this trial is testing

An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 562
Large-scale testing (Phase 3)Study completedNCT02315872
What this trial is testing

ACTH for Fatigue in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Providence Health & Services 8
Not applicableStudy completedNCT03562975
What this trial is testing

Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus

Who this might be right for
Multiple SclerosisPathologic ProcessesDemyelinating Diseases+5 more
University of South Florida 18
Post-approval studies (Phase 4)Study completedNCT00753792
What this trial is testing

Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During Relapse

Who this might be right for
Multiple Sclerosis
Germans Trias i Pujol Hospital 49
Not applicableStudy completedNCT04413682
What this trial is testing

Telerehabilitation vs Supervised Exercises in MS

Who this might be right for
Multiple Sclerosis
Istanbul University 30
Not applicableLooking for participantsNCT07292480
What this trial is testing

Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
Centre Hospitalier Universitaire de Nīmes 84
Not applicableLooking for participantsNCT06681623
What this trial is testing

A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)

Who this might be right for
Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis
Neurology Center of New England P.C. 20
Testing effectiveness (Phase 2)Study completedNCT01992679
What this trial is testing

Body Weight Supported Treadmill Training in Persons With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of Illinois at Urbana-Champaign 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06513546
What this trial is testing

Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients

Who this might be right for
Amyotrophic Lateral SclerosisALS
PLL TX AUSTRALIA PTY LTD 153
Not applicableStudy completedNCT06107023
What this trial is testing

Action Observation Training With 3D Virtual Reality in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Abant Izzet Baysal University 32
Not applicableStudy completedNCT02377323
What this trial is testing

Real-Life Outcomes of Multiple Sclerosis Treatment With Rebif

Who this might be right for
Multiple Sclerosis
Centre hospitalier de l'Université de Montréal (CHUM) 296
Not applicableStudy completedNCT05234879
What this trial is testing

The Feasibility of Frame Running as an Exercise Option for People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Queen Margaret University 10
Testing effectiveness (Phase 2)Study completedNCT01910259
What this trial is testing

MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial

Who this might be right for
Secondary Progressive Multiple Sclerosis
University College, London 445
Testing effectiveness (Phase 2)Study completedNCT00785083
What this trial is testing

The Effect of FTY720 on Pulmonary Function in Patients With Moderate Asthma

Who this might be right for
Asthma
Novartis 36
Not applicableStudy completedNCT05380362
What this trial is testing

Prospective Randomized Endovascular Therapy in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University at Buffalo 30
Not applicableNot Yet RecruitingNCT07108088
What this trial is testing

Evaluation of the NEUROSWING Orthosis on Walking Speed in a Population With Dorsal and/or Plantar Flexor Deficits, With a View to a Reimbursement Application

Who this might be right for
StrokeMultiple SclerosisCerebral Palsy+1 more
ÖSSUR France 34
Not applicableUnknownNCT05325359
What this trial is testing

L Test in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Firat University 50
Next Page